Article
Phase determination using chromosomal microarray and fluorescence in situ hybridization in a patient with early onset Parkinson disease and two deletions in PRKN.
Molecular genetics & genomic medicine - 1 May 2018
Williams Eli S, Barrett Matthew J, Dhamija Radhika, Toran Lisa, Chambers Chelsea, Mahadevan Mani S, Golden Wendy L
Abstract excerpt
BACKGROUND: Mutations in the parkin gene (PRKN) are the most commonly identified genetic factors in early onset Parkinson disease (EOPD), with biallelic mutations, resulting in a clinical phenotype. However, normal variation is also common in PRKN, particularly in the form of copy number variation (CNV), challenging interpretation of genetic testing results. Here we report a case of a 29-year-old male with EOPD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
